New-onset Diabetes Mellitus Following Successful Kidney Transplantation Facilitates Aortic Stiffening by Borda, Bernadett et al.
New-onset Diabetes Mellitus Following Successful Kidney
Transplantation Facilitates Aortic Stiffening
Bernadett Bordaa, György Lázára, Árpád Kormányosb, Péter Domsikb, Anita Kalaposb, Edit Szederkényia,
Csaba Lengyelc, Tamás Várkonyic, Csilla Keresztesd, Tamás Forsterb, and Attila Nemesb,*
aDepartment of Surgery, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary; b2nd
Department of Medicine and Cardiology Centre, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged,
Szeged, Hungary; c1st Department of Medicine, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged,
Szeged, Hungary; and dDepartment for Medical Translation and Communication, Faculty of Medicine, Albert Szent-Györgyi Clinical
Center, University of Szeged, Szeged, Hungaryª 2019 The
access artic
creativecom
230 Park Av
TransplantatABSTRACT
Background. Following kidney transplantation (KT), new-onset diabetes mellitus
(NODM) is one of the most common complications. NODM usually occurs early after
KT, and is diagnosed according to the general guidelines relevant for general diabetes
mellitus patients. Arterial stiffness is a surrogate marker of cardiovascular risk.
According to the literature, a successful KT has only limited and late beneﬁcial effects
on aortic elastic properties. The present study aimed to assess whether NODM has any
additive value on the worsening of echocardiography-derived aortic elastic properties in
transplanted patients.
Methods. We have included 28 nondiabetic post-KT patients in the study, older than 18
years (mean age: 48.2  6.9 years; 13 men, 15 women). After an oral glucose tolerance
test, 8 patients were diagnosed with NODM, and their results were compared to 23 age-,
sex-, and risk factor-matched controls (mean age: 54.9  11.0 years; 9 men, 14 women). All
post-KT patients and matched controls underwent a complete transthoracic 2-dimensional
Doppler echocardiography, together with an assessment of echocardiographic aortic
elastic properties. The assessments included aortic strain, aortic distensibility, and aortic
stiffness index.
Results. Aortic elastic properties showed alterations in post-KT patients compared to
matched controls (aortic strain: .084  .039 vs .057  .032, P < .05; aortic distensibility:
2.36  1.09 cm2/dynes 10e6 vs 1.83  1.18 cm2/dynes 10e6, P ¼ .07; aortic stiffness index:
7.15  3.58 vs 11.2  6.1, P < .05). Further deterioration in the aortic stiffness index
(14.8  7.6 vs 9.68  4.88, P < .05) was detected in the presence of NODM.
Conclusions. NODM following successful KT facilitates aortic stiffening.*Address correspondence to Attila Nemes, MD, PhD, DSc,
FESC, 2nd Department of Medicine and Cardiology Center,
Medical Faculty, Albert Szent-Györgyi Clinical Center, University
of Szeged, H-6725 Szeged, Semmelweis Street 8, Hungary, P.O.
Box 427. Tel: þ36-62-545220; Fax: þ36-62-544568. E-mail:
nemes.attila@med.u-szeged.huNEW-ONSET diabetes mellitus (NODM) is one of themost common complications following kidney trans-
plantation (KT). Untreated NODM negatively inﬂuences
allograft function and further increases the risk of cardio-
vascular diseases [1]. This issue was addressed in the 2003
Consensus Guidelines developed by the American Diabetes
Association. A diagnosis of NODM is a threat to the renal
allograft, as well as carrying the same short- and long-term
implications of type 2 diabetes mellitus (DM) seen in the
general population. NODM usually occurs early after KT,Authors. Published by Elsevier Inc. This is an open
le under the CC BY-NC-ND license (http://
mons.org/licenses/by-nc-nd/4.0/).
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to general diabetic patients. According to this, NODM is
proven if the fasting blood glucose level is  7 mmol/L, or,0041-1345/19
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test, a blood glucose level of  11.1 mmol/L 2 hours after
the oral administration of 75 g glucose [2]. The general
principle behind standardized NODM incidence reporting is
that the diagnostic criteria should reﬂect what is used in the
general population [3]. Hopefully, these developments will
allow for a more consistent reporting of NODM in the
future, leading to a more exact estimation of the incidence.
Arterial stiffness is a surrogate marker of cardiovascular
risk [4]. According to the literature, KT has only limited and
late beneﬁcial effects on aortic elastic properties [5]. Our
study aimed to assess whether NODM has any additional
beneﬁcial effects on the worsening of echocardiography-
derived aortic elastic properties in KT patients.PATIENTS AND METHODS
Our study was carried out at the Department of Surgery, University
of Szeged, Szeged, Hungary. It included 28 patients who had un-
dergone a cadaver KT within at least 1 year. All patients were above
the age of 18 years (mean age: 48.2  6.9 y; 13 men, 15 women).
Eight patients were diagnosed with NODM by oral glucose toler-
ance test. Their results were compared to those of 23 control sub-
jects (mean age: 54.9  11.0 y; 9 men, 14 women), matched with
regard to age, sex, and risk factors. Both the transplant patients and
the matched controls underwent a complete transthoracic 2-
dimensional (2D) Doppler echocardiography, extended by the
assessment of echocardiographic aortic elastic properties, which
included aortic strain, aortic distensibility, and aortic stiffness index
(ASI) [6]. Neither the KT patients nor the controls had experienced
a cardiovascular event in their medical history or had cardiovascular
symptoms at the time of examination. DM was deﬁned according to
the American Diabetes Association and World Health Organiza-
tion criteria [7,8]. Hypertension was deﬁned as either a systolic or a
diastolic elevation of blood pressure (> 140/90 mm Hg). Hyper-
cholesterolemia was deﬁned as a total cholesterol level of > 5.0
mmol/L or current treatment with lipid-lowering medications (ﬂu-
vastatin). Informed consent was obtained from each KT patient and
control subject. The institutional human research committee
approved the protocol, which conformed with the ethical guidelines
of the 1975 Declaration of Helsinki.
Biochemical Measurements
Blood samples were drawn by venipuncture to assess routine blood
parameters after 8 hours of fasting.
Immunosuppressive Therapy
The following immunosuppressive treatment was used in post-KT
patients according to the guidelines:
 Tacrolimus (Tac) is a macrolide molecule that has strong
lipophilicity. The initial daily regimen of Tac was 2 doses of
.10 mg/kg per day; the target blood trough level was 10e15 ng/mL
for 6 weeks, and 5e10 ng/mL after week 6.
 Cyclosporin-A (CsA) is a lipophilic, hydrophobic, cyclic peptide
composed of 11 amino acids. The initial regimen of CsA was 2
doses of 4e5 mg/kg per day; the target blood level was 1300e1600
ng/mL in month 1, 900e1300 ng/mL in months 2 and 3, 750e950
ng/mL in months 4e6, and 700 ng/mL afterwards (blood levels
were determined). A steroid was administered intravenously (500 mg) on day 0 in
the operating room, immediately before restoring blood ﬂow to
the graft; 125 mg was administered intravenously on day 1, 32 mg
orally on day 2, 24 mg orally on day 3, 16 mg orally on days 4e28,
12 mg orally each day during month 2, 8 mg orally each day
during month 3, and 4 mg orally during months 4e6. The dose
was further decreased in problem-free cases.
 Mycophenolate mofetil was given in two 1 g doses per day, and
was reduced by 50% or 75% in the event of gastrointestinal
symptoms or leucopenia.
Blood Pressure Measurement
Systolic and diastolic blood pressures (SBP and DBP, respectively)
were measured with a sphygmomanometer using an inﬂatable cuff
and a mercury manometer positioned on the left arm in supine
position after 10 min of rest. Appearance of a tone (ﬁrst) and
disappearance (ﬁfth) of Korotkoff sounds corresponded with SBP
and DBP. No stimulant consumption (caffeine) was allowed for 30
minutes prior to the blood pressure measurements. Three consec-
utive blood pressure measurements were averaged and used as
blood pressure data [9].
2D Doppler Echocardiography
Transthoracic imaging and measurements were carried out using a
Toshiba Artida echocardiography system (ToshibaMedical Systems,
Tokyo, Japan) with a 1e5MHz PST-30SBP phased-array transducer.
While in the left lateral decubitus position, all patients underwent a
complete 2D Doppler echocardiographic study. Left ventricular di-
ameters, volumes and ejection fractions, left atrial diameter, and
aortic dimensions respecting the cardiac cycle were measured ac-
cording to the recent guidelines [10]. All echocardiographic mea-
surements were averaged from 3 beats. The degree of valvular
regurgitation was visually quantiﬁed, and valvular stenosis was
excluded by color Doppler echocardiography according to clinical
practice. Mitral inﬂow E/A was measured by pulsed Doppler.
Assessment of Echocardiographic Aortic Elastic Properties
Systolic and diastolic ascending aortic diameters (SD and DD,
respectively) were recorded during M-mode echocardiography at a
level of 3 cm above the aortic valve in the parasternal long-axis view
according to the literature [9]. SD and DD were measured at the
time of maximum aortic anterior motion and at the peak of the
QRS complex, respectively. The following aortic elastic indices were
calculated:
 Aortic strain¼ (SD eDD) /DD
 Aortic stiffness index (b) ¼ ln (SBP /DBP) / [(SD-DD) /DD],
where ln is the natural logarithm.
 Aortic distensibility ¼ 2 x (SD-DD) / [(SBP-DBP)DD].
Statistical Analysis
Continuous variables are expressed as mean  standard deviation,
whereas dichotomous variables are expressed as absolute and
relative frequencies (percentages). Continuous variables were
compared with the unpaired Student t test, while categorical vari-
ables were examined using the c2 test and Fisher exact test. A
Pearson correlation coefﬁcient was calculated featuring the nu-
merical correlation. Statistical tests were 2-sided, and a P value
< .05 was considered to be statistically signiﬁcant. Statistical ana-
lyses were carried out by using MedCalc software (MedCalc,
Ostend, Belgium).
Table 1. Relevant Clinical Data in the Study Groups
Matched Healthy
Controls (n ¼ 23)
All KT Patients
(n ¼ 28)
KT Patients
Without NODM (n ¼ 20)
KT Patients
With NODM (n ¼ 8)
Clinical data
Age (y) 54.9  11.0 48.2  6.9 46.1  6.4 53.6  4.8*
Male sex (%) 9 (39) 13 (46) 8 (40) 5 (63)
Hypertension (%) 17 (74) 22 (79) 15 (75) 7 (88)
Hypercholesterolemia (%) 6 (26) 6 (21) 4 (20) 2 (25)
Diabetes mellitus (%) 4 (17) 8 (29) 0 (0) 8 (100)*,†
Weight (kg) 89.2  18.2 75.5  13.6 74.7  11.0 77.4  19.6
Height (m) 162.6  6.2 168.6  8.6 169.1  8.8 167.4  8.6
Medication
b-blocker (%) 4 (17) 12 (43) 7 (35) 5 (63)†
ACE inhibitor or ARB (%) 10 (44) 18 (64) 13 (65) 5 (63)
Ca-antagonist (%) 4 (17) 8 (29) 4 (20) 4 (50)
Antidiabetics (%) 3 (13) 5 (18) 0 (0) 5 (63)†
Statin (%) 3 (13) 11 (39) 7 (35) 4 (50)†
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; Ca, calcium; NODM, new-onset diabetes mellitus following kidney
transplantation.
*P < .05 vs renal transplant without NODM.
†P < .05 vs matched controls.
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Clinical Data, Medications and Laboratory Findings
There were 20 patients in the non-NODM group and 8
patients in the NODM group. The clinical data and subse-
quent medications are presented in Table 1. All post-KT
patients received a triple combination that consisted of
calcineurin inhibitor (23 patients Tac, 5 patients CsA),
mycophenolate mofetil, and steroids. Only 5 of the 8
NODM patients required antidiabetic treatment: 3 of them
were put on insulin, and 2 were administered oral antidia-
betics. Three patients were not given any treatment, as their
abnormal glucose metabolism was identiﬁed only during the
examination. All post-KT patients received antihypertensive
treatment with double (calcium channel blocker and
angiotensin-converting enzyme inhibitors) or triple combi-
nation (calcium channel blocker, angiotensin-converting
enzyme inhibitors, and b blocker). The results of the labo-
ratory tests showed higher serum urea (17.4  10.4 mmol/L
vs 8.6  2.9 mmol/L, P < .05), creatinine (209.6  104.2
mmol/L vs 121.7  30.1 mmol/L, P < .05), fasting glucose
(7.6  1.5 mmol/L vs 5.5  .7 mmol/L, P < .05), and HbA1c
(6.9  .8% vs 5.7  .4%, P < .05), as well as a lowerTable 2. 2D Doppler Echocardiographic
Matched Controls
(n ¼ 23)
All Renal Trans
Patients (n ¼
LA diameter (mm) 38.1  3.2 39.9  4.9
LV-EDD (mm) 46.2  4.0 53.1  5.1
LV-ESD (mm) 29.3  3.9 31.7  4.1
IVS (mm) 10.0  1.2 11.0  .9*
LV-PW (mm) 9.7  1.1 11.0  1.2
LV-EF (%) 65.2  6.4 68.4  5.2
E/A ratio .95  .25 .97  .26
Abbreviations: E/A, ratio of E and A transmitral ﬂow velocities; EDD, end-diastolic
ventricular; NODM, new-onset diabetes mellitus following kidney transplantation; PW
*P < .05 vs matched controls.
†P < .05 vs renal transplant without NODM.estimated glomerular ﬁltration rate (35.3  23.9 vs 57.3 
15.9, P < .05) in NODM post-KT patients compared with
nondiabetic post-KT cases.
2D Echocardiography Data
The results of the routine 2D echocardiographic studies are
presented in Table 2. None of the KT patients and their
matched controls showed a grade 1 or higher mitral or
tricuspid regurgitation, or had a signiﬁcant valvular stenosis.
Blood Pressure, Aortic and Aortic Distensibility Data
Results are presented in Table 3. Aortic elasticity properties
showed alterations in post-KT patients, and further im-
pairments were detected in the presence of NODM.DISCUSSION
Arterial stiffness is an age-related process, a shared conse-
quence of several disorders, including DM and chronic
kidney disease (CKD) [11,12]. Different cardiovascular pa-
rameters, including arterial stiffness, have been shown to
have a prognostic value in CKD [12]. KT is a widely usedParameters in the Examined Groups
plant
28)
Renal Transplant
Without NODM (n ¼ 20)
Renal Transplant
With NODM (n ¼ 8)
39.3  5.3 41.5  3.6
* 52.4  5.1* 54.8  5.2*
* 31.4  4.0 32.5  4.5
10.8  0.8* 11.5  1.5*
* 10.9  1.0* 11.5  1.5*
68.7  5.2 67.9  5.7
1.04  .25 .75  .14*,†
; EF, ejection fraction; ESD, end-systolic; IVS, interventricular septum; LV, left
, posterior wall.
Table 3. Blood Pressure and 2D Echocardiography-derived Aortic Elastic Properties in Groups Examined
Matched Controls
(n ¼ 23)
All Renal Transplant
Patients (n ¼ 28)
Renal Transplant
Without NODM (n ¼ 20)
Renal Transplant
With NODM (n ¼ 8)
Systolic blood pressure (mm Hg) 139.6  14.2 129.7  15.1* 127.4  12.4* 135.6  20.3
Diastolic blood pressure (mm Hg) 85.7  9.9 79.7  8.9 79.1  12.4* 81.3  9.9
Pulse pressure (mm Hg) 53.9  11.8 48.3  16.4 48.3  12.0 54.4  17.6
Systolic aortic diameter (mm) 29.2  3.9 31.3  3.0* 31.2  3.0 31.6  3.2
Diastolic aortic diameter (mm) 26.9  3.7 29.6  3.2* 29.4  3.2* 30.4  3.3*
Pulsatile change in aortic diameter (mm) 2.22  1.00 1.63  .82* 1.80  .87 1.23  .53*
Aortic strain 0.084  .039 .057  .032* .063  .034 .041  .019*
Aortic distensibility (cm2/dynes 10e6) 2.36  1.09 1.83  1.18‡ 2.08  1.29 1.21  .56*
Aortic stiffness index 7.15  3.58 11.2  6.1* 9.68  4.88* 14.8  7.6*,†
Abbreviation: NODM, new-onset diabetes mellitus following kidney transplantation.
*P < .05 vs matched controls.
†P < .05 vs renal transplant without NODM.
‡P ¼ .07 vs matched controls.
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relatively common entity in KT recipients. Some risk factors
have been identiﬁed as predating the transplant, and could
be used for risk-stratiﬁcation and to implement the proper
strategies for risk-reduction [14]. Several clinical studies
have shown that serum creatinine and estimated glomerular
ﬁltration rate levels are higher in NODM patients [15,16].
These results were conﬁrmed by the ﬁndings of our study.
We detected signiﬁcant differences between the nondiabetic
and NODM post-KT patients with regard to the renal lab-
oratory parameters. NODM was also found to be associated
with decreased graft survival and an increased risk for the
development of cardiovascular disease [17].
There are several ways to assess arterial stiffness, including
pulse wave analysis and the measurement of pulse wave ve-
locity (PWV) by tonometry, oscillometry, or sonography [9].
However, there is another method, several aortic elasticity
properties can be calculated by imaging (for instance, by
echocardiography) using aortic dimensions with respect to
the cardiac cycle and forearm blood pressure values [9]. It has
been demonstrated that the noninvasively evaluated ASI is
comparable to invasive methods and achieves a high degree
of accuracy [18]. A recent study has demonstrated an
improvement of aortic elastic properties including echocar-
diographic ASI after KT [5]. The most signiﬁcant changes of
these indices can be observed only between years 1e3 after
KT. This continuous and prolonged improvement process
suggests a reverse remodeling. In our study, ASI 1 year after
the operation was signiﬁcantly higher in KT patients
compared to matched controls and was proven to be more
pronounced in patients who developed NODM. In our study,
ASI was proven to be higher compared to the ﬁndings of
others in KT patients [5]. The PWV was determined by
pressure tracing over the carotid and femoral arteries.
Another study found that ASI was signiﬁcantly higher in
transplant recipients with NODM compared to transplant
patients without NODM [19]. These results are conﬁrmed by
Kato et al, who used brachial-ankle PWV measurements in
their assessment [20]. In these studies, determinants for PWV
have been identiﬁed as an increase in SBP and recipients’ age.
They conform with our ﬁndings, which also demonstratedhigher aortic stiffness values in NODM patients [19e20].
These results could be explained by DM-related vascular al-
terations and endothelial dysfunction, and they could suggest
the importance of regular control of carbohydrate meta-
bolism in KT patients. Multidisciplinary care of the kidney
recipients should be managed by a common team, and a
minimum of 1 clinical control is required every year. Further
studies are warranted to examine whether echocardiographic
ASI has a real prognostic value in KT patients.
ACKNOWLEDGMENTS
We wish to thank the Hungarian Diabetes Association and Novo
Nordisk for their joint grant in 2017.REFERENCES
[1] Coiso FG, Kudva Y, van der Velde M, et al. New onset hy-
perglycemia and diabetes are associated with increased cardiovas-
cular risk after kidney transplantation. Kidney Int 2005;67:2415e21.
[2] American Diabetes Association. Diagnosis and classiﬁcation
of diabetes mellitus. Diabetes Care 2010;33:S62e9.
[3] Davidson J, Wilkinson A, Dantal J, et al. International expert
panel: New-onset diabetes after transplantation: 2003 International
consensus guidelines. Proceedings of an international expert panel
meeting. Barcelona, Spain, 19 February 2003. Transplantation
2003;75:S3e24.
[4] Laurent S. Arterial stiffness: intermediate or surrogate
endpoint for cardiovascular events? Eur Heart J 2005;26:1152e4.
[5] Zapolski T, Furmaga J, Jaroszynski A, et al. The reverse
remodeling of the aorta in patients after renal transplantationdthe
value of aortic stiffness index: prospective echocardiographic study.
BMC Nephrol 2017;18:33.
[6] Townsend RR. Arterial stiffness in CKD: A review. Am J
Kidney Dis 2019;73:240e7.
[7] American Diabetes Association. American Diabetes Associ-
ation home page. www.diabetes.org. [Accessed 21.11.18].
[8] World Health Organization. Diabetes. www.who.int/diabetes/
en. [Accessed 21.11.18].
[9] Nemes A, Geleijnse ML, Forster T, et al. Echocardiographic
evaluation and clinical implications of aortic stiffness and coronary
ﬂow reserve and their relation. Clin Cardiol 2008;31:304e9.
[10] Lang RM, Badano LP, Mor-Avi V, et al. Recommendations
for cardiac chamber quantiﬁcation by echocardiography in adults:
an update from the American Society of Echocardiography and the
European Association of Cardiovascular Imaging. Eur Heart J
Cardiovasc Imaging 2015;16:233e70.
NEW-ONSET DIABETES AND AORTIC STIFFENING 1243[11] Prenner SB, Chirinos JA. Arterial stiffness in diabetes
mellitus. Atherosclerosis 2015;238:370e9.
[12] Chen SC, Huang JC, Su HM, et al. Prognostic cardiovas-
cular markers in chronic kidney disease. Kidney Blood Press Res
2018;43:1388e407.
[13] Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney dis-
ease as a risk factor for development of cardiovascular disease: a
statement from the American Heart Association Councils on Kid-
ney in Cardiovascular Disease, High Blood Pressure Research,
Clinical Cardiology, and Epidemiology and Prevention. Circulation
2003;108:2154e69.
[14] Alagbe SC, Voster A, Ramesar R, Swanepoel CR. New-
onset diabetes after transplant: incidence, risk factors and outcome.
S Afr Med J 2017;107:791e6.
[15] Borda B, Szederkényi E, Lengyel C, et al. Functional and
histopathological changes in renal transplant with new onset dia-
betes and dyslipidemia. Transplant Proc 2011;43:1254e8.[16] Gámán G, Sárváry E, Gelley F, et al. New-onset diabetes
mellitus and the analysis of dipeptidyl-peptidase-4 after liver
transplantation. Transplant Proc 2014;46:2177e80.
[17] Sezer S, Erkmen Uyar M, Tutal E, et al. New-onset diabetes
and glucose regulation are signiﬁcant determinants of left ventric-
ular hypertrophy in renal transplant recipients. J Diabetes Res
2015;2015:293896.
[18] Stefanadis C, Stratos C, Boudoulas H, Kourouklis C,
Toutouzas P. Distensibility of the ascending aorta: comparison of
invasive and non-invasive techniques in healthy men and in men
with coronary artery disease. Eur Heart J 1990;11:990e6.
[19] Opazo Saez A, Kos M, Witzke O, Kribben A, Nürnberger J.
Effect of new-onset diabetes mellitus on arterial stiffness in renal
transplantation. Transpl Int 2008;10:930e5.
[20] Kato K, Matsuhisa M, Ichimaru N, et al. The impact of new-
onset diabetes on arterial stiffness after renal transplantation.
Endocr J 2008;55:677e83.
